State Street Corp. Updates Passive Stake in Ocugen Inc.
Ticker: OCGN · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, amendment, biotechnology
TL;DR
**State Street still owns Ocugen shares, signaling continued institutional interest.**
AI Summary
State Street Corporation, a major financial institution, filed an amended Schedule 13G/A on January 22, 2024, indicating its ownership of Ocugen Inc. common stock as of December 31, 2023. This filing updates their previous disclosure, showing their continued passive investment in the biotechnology company. This matters to investors because it confirms a significant institutional holder maintains its position, which can be seen as a vote of confidence, though the exact percentage of ownership isn't detailed in the provided snippet.
Why It Matters
This filing confirms that a large institutional investor, State Street Corporation, continues to hold shares in Ocugen Inc., which can provide a level of stability and institutional backing for the stock.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate risk or significant change in company fundamentals.
Analyst Insight
Investors should note that a major institutional player like State Street Corporation continues to hold Ocugen stock, suggesting a baseline level of confidence, but this filing alone doesn't signal a new buying opportunity or a change in company prospects. It's a routine update of a passive investment.
Key Numbers
- 12/31/2023 — Date of Event (This is the snapshot date for the ownership reported by State Street Corporation.)
- 0000093751-24-000060 — Accession Number (Unique identifier for this specific SEC filing.)
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Ocugen, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event which required the filing
- 04-2456637 (number) — State Street Corporation's IRS Identification No.
- 67577C105 (number) — the CUSIP number for Ocugen Inc. common stock
Forward-Looking Statements
- State Street Corporation will maintain a significant, passive stake in Ocugen Inc. throughout 2024. (State Street Corporation) — medium confidence, target: 2024-12-31
FAQ
What is the purpose of an SC 13G/A filing?
An SC 13G/A is an amendment to a Schedule 13G, which is filed by institutional investors who acquire more than 5% of a company's stock but intend to remain passive investors. The '/A' indicates it's an amendment to a previously filed statement, updating the information, as seen with State Street Corporation's filing for Ocugen Inc. common stock.
Who filed this specific SC 13G/A and for which company?
This SC 13G/A was filed by State Street Corporation (IRS Identification No. 04-2456637) regarding its ownership of common stock in Ocugen, Inc. (CUSIP NO: 67577C105).
What was the 'Date of Event' that triggered this filing?
The 'Date of Event Which Requires Filing of This Statement' was December 31, 2023, as stated in the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13D-1 (B), as indicated by the 'X' next to 'RULE 13D-1 (B)' in the filing.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Ocugen Inc. is 67577C105, as specified in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding Ocugen, Inc. (OCGN).